Login

Clinical

  • Clinical Solutions
  • AI solutions portfolio

Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.

Learn more

Research

  • Research solutions
  • Aiforia® Create
  • AI solutions portfolio

Aiforia’s research solutions offer fully automated study-centric workflows and pathology image analysis applications that cater to all research areas. Empowered by robust AI capabilities, pathologists and scientists can make discoveries while saving time by automating repetitive tasks – also within the framework of GLP. Aiforia’s solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.

Learn more

Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.Learn more >

Learn more

Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.

Learn more

AI development tool

  • Aiforia® Create

Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.

Learn more

Resources

  • Publications
  • Resource Library
  • Press releases

Explore some of our latest publications showcasing the discoveries enabled by the Aiforia® Platform.

Learn more

Aiforia's insights and resources for AI in pathology. View some of our content pieces from the world of AI.

Learn more

Stay updated with Aiforia’s recent announcements. Explore our latest news, updates and announcements.

Learn more

Company

  • About us
  • Investors
  • Partners
  • Media
  • Events
  • Careers
  • Quality and security

Find out more about shareholder matters, investment discussions, and financial-related information.

Learn more

Aiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient. To succeed, we need our trusted partners. Explore Aiforia’s partner network.

Learn more

Experience our AI solutions firsthand. Explore the list of conferences where you can connect with Aiforia’s team live and book a time to discover the future of AI-powered image analysis.

Learn more

Our mission is to transform pathology image analysis with AI, enabling better care for each patient. Find out more about job openings, thesis opportunities, or submitting applications.

Learn more

Aiforia Technologies holds information security to the highest standard. We hold several, globally relevant quality and security certifications, so you can be sure your sensitive information is safe.

Learn more
Contact us
Login

Clinical

Clinical Solutions

All clinical solutions Breast Cancer Suite Lung Cancer Suite Prostate Cancer Suite Gastric Suite

Prognostic solutions

Colorectal Cancer QuantCRC

AI solutions portfolio

Learn more

Research

Research solutions

Learn more

Aiforia® Create

Learn more

AI solutions portfolio

Learn more

AI development tool

Aiforia® Create

Learn more

Resources

Publications

Learn more

Resource Library

Learn more

Press releases

Learn more

Company

About us

About Aiforia Leadership

Investors

Learn more

Partners

Learn more

Media

Media room Press releases

Events

Learn more

Careers

Learn more

Quality and security

Learn more
Contact us

Media room

Stay updated with Aiforia’s recent announcements, explore high-quality images, and find essential information about the company.

PD-L1_monitor_right angle-1

Aiforia in the news

Discover the latest articles featuring Aiforia.

Hospitalia

Aiforia has been featured by Hospitalia for its role in supporting the digital transformation of anatomical pathology at the CHU de Nantes through AI-powered diagnostic workflows.

Available only in French
January 5, 2026

Nordic Life Science

Aiforia has been featured by Nordic Life Science for its contribution to the Finnish cancer research ecosystem, utilizing AI-powered image analysis to enhance the speed and accuracy of pathology diagnoses.

December 17, 2025

YLE

Aiforia has been featured by Yle, Finland's national public service media company, as an example of a Finnish AI company driving economic growth by focusing on the specific needs of healthcare.

Available only in Finnish
April 11, 2025

SIH

Artificial Intelligence decision-making and diagnosis automation in the Pathological Anatomy Department of Bicêtre Hospital

Available only in French
January 29, 2025

Mediuutiset

Artificial intelligence was able to use pathological images to predict how an ovarian cancer patient would respond to chemotherapy

Available only in Finnish
October 25, 2024

Corriere dell'Economia

Artificial intelligence in nephrology: a project of the University of Verona

Available only in Italian
October 7, 2024

Kauppalehti

Aiforia receives an order from Finland’s largest healthcare laboratory company

Available only in Finnish
August 1, 2024

CAP Today

Mayo pathologists create and test their own AI algorithms

July 22, 2024

Agence France Presse

Artificial intelligence clarifies cancer diagnoses in one click in a French hospital

Available only in French
April 8, 2024

International Business Times

Aiforia Disrupts Cancer Diagnostics With Supervised AI For A More Precise And Efficient Healthcare Future

March 26, 2024

Kauppalehti

A huge growth market: this Helsinki Stock Exchange company is one of the beneficiaries of the AI boom

Available only in Finnish
February 9, 2024

FierceBiotech

Mayo Clinic lines up AI collabs in colon, breast cancer with Aiforia, SimBioSys

January 2, 2024
View all featured articles

Press releases

Explore our latest news, updates, and announcements.

June 11, 2026

Aiforia expands its presence in Spain through a new clinical account

Aiforia Technologies Plc, Press Release, June 11, 2026 at 9:30 a.m. EEST Aiforia Technologies has been selected to provide AI-assisted diagnostic solutions to a regional health service provider in Spain. The public tender was won by Palex, Aiforia’s strategic med tech partner in Spain. Under the agreement, Aiforia will equip nine hospitals across the region with AI applications for breast and ...
April 27, 2026

Fimlab expands utilization of Aiforia's clinical AI solutions

Aiforia Technologies Plc, Press Release, April 27, 2026 at 9:00 a.m. EEST Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical workflow. Already in 2025, as part of the first deployment batch under the framework agreement, Fimlab implemented Aiforia’s breast cancer diagnostics solution – a complete suite ...
April 23, 2026

Aiforia closes a deal with a private diagnostic laboratory in Italy

Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. Using Aiforia’s distinct AI development platform, Aiforia® Create, the laboratory La Fontana aims to develop deep learning AI models for ...
April 16, 2026

Aiforia has been selected as an AI partner for the PROSTIA project - expands to five new hospitals in Paris

Aiforia Technologies Plc, Press Release, April 16, 2026 at 12:00 a.m. EEST Aiforia France, a subsidiary of Aiforia Technologies Plc, has been selected as the AI partner for the PROSTIA project led by Assistance Publique–Hôpitaux de Paris (AP-HP). This initiative will deploy Aiforia’s CE-IVD-marked prostate cancer diagnostic solution across all AP-HP pathology sites involved in the management of ...
March 17, 2026

Aiforia announces the next generation of its CE-IVD marked Prostate Cancer Biopsy AI solution

Aiforia Technologies Plc, Press Release, March 17, 2026 at 9:30 a.m. EET Aiforia Technologies Plc today announced the launch of the next generation of its clinical AI solution for prostate cancer diagnostics. The Aiforia® Prostate Cancer Biopsy AI application is designed to enhance pathologists’ diagnostic workflow by providing world-class tools for comprehensive analysis and reporting of ...
March 10, 2026

Aiforia and Proscia partner to accelerate AI-driven digital pathology

Aiforia Technologies Plc, Press Release, March 10, 2026 at 10:00 a.m. EET Aiforia, a pioneer in AI-driven diagnostics in pathology, and Proscia, a pathology AI company, announced a partnership to accelerate the global adoption of AI-driven workflows in anatomic pathology laboratories.
February 2, 2026

Aiforia releases a new CE-IVD marked AI solution for gastric cancer diagnostics

Aiforia Technologies Plc, Press Release, February, 2026 at 10:00 a.m. EET Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is designed to support pathologists in the detection and reporting of gastric cancer in digitized gastric tissue samples.
December 23, 2025

Aiforia's 2025: Landmark year of clinical deployments and regulatory approvals

Dear customers, partners, shareholders, and our team, As we enter a new year filled with possibilities, I want to reflect on the impact we made in 2025. Aiforia is making significant strides toward its core mission of revolutionizing pathology image analysis with AI and delivering improved care for every patient. I am immensely proud of our collective accomplishments and energized for the ...
December 17, 2025

Aiforia launches next-generation AI technology platform

Aiforia Technologies Plc, Press Release, December 17, 2025 at 9:00 a.m. EET Aiforia Technologies Plc announces the expansion of its AI technology platform featuring the Vision Transformer architecture. Leveraging patent-pending innovation, Aiforia’s new Foundation Engine overcomes the common hurdles faced with foundation models. It delivers rapid execution and cost-efficient processing for both ...
November 28, 2025

Aiforia receives the Jacques Cresson Award

Aiforia, a leading provider of AI-powered solutions for digital pathology, has been honored with the Jacques Cresson Award, granted by the French Foreign Trade Advisors (Conseillers du Commerce Extérieur de la France – CCE). The award recognizes organizations for their significant contribution to strengthening France's international influence through innovation, global ambition, and tangible ...
October 27, 2025

Aiforia selected by Institut Curie for AI-assisted cancer diagnostics

Aiforia Technologies Plc, Press Release, October 27, 2025 at 10:30 a.m. EET Institut Curie in France has selected Aiforia Technologies as a partner for AI-assisted diagnostics in pathology. The collaboration involves utilizing Aiforia’s CE-IVD marked clinical AI solutions for breast and prostate cancer diagnostics. These solutions provide a comprehensive digital platform, powered by multiple AI ...
October 22, 2025

Aiforia signs a local agreement with Siemens Healthineers Finland

Aiforia Technologies Plc, Press Release, October 22, 2025 at 10:30 a.m. EEST Aiforia Technologies, a leading Finnish provider of deep learning AI solutions for digital pathology, has entered into a local agreement with Siemens Healthineers Finland. The partnership focuses on joint co-marketing and sales efforts, leveraging Siemens Healthineers Finland’s strong regional network and expertise in ...
View all press releases

Media assets

Access high-quality media assets, including images, videos, and logos, for your storytelling needs.

 

 

Aiforia logos


Download iconDownload logos

Product images


Download iconDownload images

Photos of the CEO


Download iconDownload photos

Fact sheet


Download iconDownload factsheet

Videos


Download iconDownload videos

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers advanced software solutions that elevate diagnostic capabilities in image analysis, empowering remarkable medical discoveries both today and in the future. With thousands of AI models developed for research use and several diagnostic solutions deployed, Aiforia is making a significant impact on pathology and healthcare. In Europe, Aiforia is the leading provider of CE-IVD marked AI-powered solutions for digital pathology. 

Founded in 2013, Aiforia is a publicly traded company with a global presence and thousands of users worldwide. Headquartered in Helsinki, Finland, the company also operates subsidiaries in the United States and France, and maintains a network of local representatives across Europe and North America. Aiforia’s diverse team includes experienced AI and software developers, pathologists, medical scientists, and a dedicated commercial team. Together, they are transforming pathology through AI, enabling better care for every patient. 

 

Rectangle 346

Media contact

The Aiforia comms team is happy to help with any media inquiries, such as requests for interviews and additional materials.

media@aiforia.com